How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

And that could be a good thing ...

It’s become a trope in Silicon Valley to liken the rise of AI to t. Hardcore AI true-believers often say that the rise of ...

ACRouter, a new open-source AI router, learns from execution feedback to pick the best coding model per task, cutting costs 2 ...

OpenAI has talked about how having an automated AI researcher was on its roadmap, and it’s shown the first glimpses of that ...

Artificial intelligence is rewriting the world and simultaneously inventing a whole new language to describe how it’s doing it. Sit in on any product meeting, pitch, or panel these days, and you’ll ...

The loop takes agentic AI a step further by authorizing a swarm of agents to work continuously in the background, endlessly.

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Good morning, everyone, and thank you for joining us. Since stepping into this role, I've been focused on a singular question: how do we harness the full power of AI to consistently and with urgency ...

Earnings call Recursion Pharmaceuticals delivered strong operational progress with a 30% YoY reduction in operating expenses and an extended cash runway into early 2028. Clinical momentum was ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Hello, and welcome, everybody, to Recursion's Q2 2025 Earnings Call. My name is Chris Gibson, and I'm the Co-Founder and CEO of Recursion. And I'm excited to share with you today some of the latest ...